中国药物警戒 ›› 2014, Vol. 11 ›› Issue (8): 478-481.

• 政策与法规研究 • 上一篇    下一篇

英国药物警戒检查简介及启示

董铎, 吴桂芝, 王丹, 冯红云, 王亚丽, 程刚   

  1. 国家食品药品监督管理总局药品评价中心,北京 100045
  • 收稿日期:2016-02-03 修回日期:2016-02-03 出版日期:2014-08-08 发布日期:2016-03-02
  • 作者简介:董铎,女,博士,副主任药师,药品不良反应监测。

Overview of Pharmacovigilance Inspection in UK

DONG Duo, WU Gui-zhi, WANG Dan, FENG Hong-yun, WANG Ya-li, CHENG Gang   

  1. Center For Drug Reevaluation, CFDA, Beijing 100045, China
  • Received:2016-02-03 Revised:2016-02-03 Online:2014-08-08 Published:2016-03-02

摘要: 为促进药品安全第一责任人即药品生产企业上市后监测责任的落实,英国于2003年启动了药物警戒检查项目,目前已经形成了一套完整的检查体系。通过对英国药物警戒检查类型、检查流程、检查结果等内容介绍,提出了对我国生产企业药品不良反应报告和监测的检查分工、检查指南、自我检查指标体系以及信息沟通方面的思考和建议。

关键词: 英国, 药物警戒, 药品不良反应, 检查

Abstract: To promote pharmaceutical manufacturer, the first person for products safety to undertake post-marketing surveillance responsibility,UK initiated pharmacovigilance inspection programme in 2003, and now it formed a set of complete inspection system.This article introduced pharmacovigilance inspection type, process, findings and so on in UK, and proposed recommendation on adverse drug reaction report and monitoring inspection responsiblity division, guideline, self-checking indicatior system and information communication.

Key words: UK, pharmacovigilance, adverse drug reaction, inspection

中图分类号: